| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 |
| filingDate |
2007-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92da9d2b2b7f3a49f3069a8c2490b993
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bc3965b1eff3f5fbd43746e2f70ffe9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8619676da1f86af368b3cf18db69c27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf44d9cf9b47540648de1d2391b94c6d |
| publicationDate |
2007-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2645093-A1 |
| titleOfInvention |
Use of adenine-derived compounds for the treatment of lupus |
| abstract |
The invention relates to the use of adenine-derived compounds substituted at the 2- and 9-positions, and optionally N (6) of adenine, for the manufacture of a medicament for the treatment of systemic lupus erythematosus (SLE). . The compounds can also be used in combination with a second compound used in the treatment of LEDs. |
| priorityDate |
2006-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |